首页> 外文期刊>The Journal of Physiology >Exogenous and endogenous angiotensin-II decrease renal cortical oxygen tension in conscious rats by limiting renal blood flow
【24h】

Exogenous and endogenous angiotensin-II decrease renal cortical oxygen tension in conscious rats by limiting renal blood flow

机译:外源性和内源性血管紧张素-II通过限制肾血流量降低神志清楚的大鼠的肾皮质氧张力

获取原文
获取原文并翻译 | 示例
       

摘要

We hypothesised that both exogenous and endogenous angiotensin-II (AngII) can decrease the partial pressure of oxygen (PO2) in the renal cortex of unrestrained rats, which might in turn contribute to the progression of chronic kidney disease. Rats were instrumented with telemeters equipped with a carbon paste electrode for continuous measurement of renal cortical tissue PO2. The method reproducibly detected acute changes in cortical oxygenation induced by systemic hyperoxia and hypoxia. In conscious rats, renal cortical PO2 was dose-dependently reduced by intravenous AngII. Reductions in PO2 were significantly greater than those induced by equi-pressor doses of phenylephrine. In anaesthetised rats, renal oxygen consumption was not affected, and filtration fraction was increased only in the AngII infused animals. Oxygen delivery decreased by 50% after infusion of AngII and renal blood flow (RBF) fell by 3.3mlmin(-1). Equi-pressor infusion of phenylephrine did not significantly reduce RBF or renal oxygen delivery. Activation of the endogenous renin-angiotensin system in Cyp1a1Ren2 transgenic rats reduced cortical tissue PO2. This could be reversed within minutes by pharmacological angiotensin-II receptor type 1 (AT(1)R) blockade. Thus AngII is an important modulator of renal cortical oxygenation via AT(1) receptors. AngII had a greater influence on cortical oxygenation than did phenylephrine. This phenomenon appears to be attributable to the profound impact of AngII on renal oxygen delivery. We conclude that the ability of AngII to promote renal cortical hypoxia may contribute to its influence on initiation and progression of chronic kidney disease.
机译:我们假设外源性和内源性血管紧张素II(AngII)均可降低不受约束的大鼠肾皮质中的氧分压(PO2),这反过来可能有助于慢性肾脏疾病的进展。用配备有碳糊电极的遥测仪对大鼠进行测量,以连续测量肾皮质组织PO2。该方法可重现性检测由系统性高氧和缺氧引起的皮层充氧的急性变化。在清醒的大鼠中,静脉内AngII剂量依赖性地降低了肾皮质PO2的浓度。 PO2的减少明显大于等压剂量的去氧肾上腺素引起的减少。在麻醉的大鼠中,肾氧消耗不受影响,并且仅在注入AngII的动物中过滤分数增加。输注AngII后,氧气输送量降低了50%,肾血流量(RBF)下降了3.3mlmin(-1)。等压输注去氧肾上腺素并没有显着降低RBF或肾氧输送。 Cyp1a1Ren2转基因大鼠中内源性肾素-血管紧张素系统的激活减少了皮质组织PO2。药理性血管紧张素II受体1型(AT(1)R)阻断作用可在数分钟内逆转这种情况。因此,AngII是通过AT(1)受体对肾皮质充氧的重要调节剂。与去氧肾上腺素相比,AngII对皮层氧合的影响更大。这种现象似乎归因于AngII对肾氧输送的深远影响。我们得出结论,AngII促进肾皮质缺氧的能力可能有助于其对慢性肾脏疾病的发生和发展的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号